Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 39 for “"SRSF2"”.

  1. Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy

    … (SF). Recurrent mutations in the splicing factor SRSF2 occur frequently in myeloid neoplasms and portend a poor prognosis. To determine how mutations in SRSF2 alter its function in vivo, hematopoietic cell lines with inducible expression of Flag-tagged SRSF2WT and SRSF2P95H were generated. …

    freiburg-diss Repository record for Elucidation of a hypersplicing phenotype in SRSF2 mutant myeloid malignancy (opens in a new tab)

  2. Exploring the capability of mutant SRSF2 to elicit an innate immune response in myeloid malignancies

    … another commonly mutated spliceosome component, SRSF2, confers a DDRD and whether this could be exploited for combination therapies with ICIs. A CRISPR/Cas9-genertaed isogenic K-562 model harbouring the common SRSF2P95H mutation was used throughout this study. Immunofluorescence imaging of 53BP1 …

    qu-belfast Repository record for Exploring the capability of mutant SRSF2 to elicit an innate immune response in myeloid malignancies (opens in a new tab) Embargoed until 2030-07-31

  3. The cellular splicing regulator SRSF2 controls HPV16 E6 mRNA stability and contributes to the cervical tumour phenotype

    … upon cervical epithelial transformation. For SRSF2 and 3, this was not due to gene amplification as qPCR analysis of gene copy number showed no significant difference in CT values between the W12 cell lines suggesting that upregulation of SRSF2 and 3 may be at a transcriptional level. However …

    glasgow Download PDF for The cellular splicing regulator SRSF2 controls HPV16 E6 mRNA stability and contributes to the cervical tumour phenotype (opens in a new tab)

  4. An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes

    … in splicing factor genes (including SF3B1, SRSF2 and U2AF1) occur in over half of MDS patients and result in aberrant pre-mRNA splicing of many target genes, indicating that aberrant spliceosome function plays a key role in the pathogenesis of MDS. However, the molecular mechanisms through …

    oxford Repository record for An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes (opens in a new tab)

  5. Alternatively Spliced CSF3R in Human Health and Disease

    … on the role of an MDS-associated splicing factor SRSF2 and its effects on the production of Class III and Class IV CSF3R isoforms and granulopoiesis. Class IV add-back in Csf3r-null mice showed impaired neutrophil differentiation with increased number of CFU-G, which largely consisted of …

    vcu Repository record for Alternatively Spliced CSF3R in Human Health and Disease (opens in a new tab)

  6. CRISPR/Cas9 based modelling of chronic myelomonocytic leukaemia

    … mutations in CMML occur in the TET2 (∼60%), SRSF2 (∼50%) and RAS (∼30%) genes (Patnaik & Tefferi, 2022). Co mutation of TET2 with SRSF2 has been shown to be highly predictive of a CMML disease phenotype (specificity of 98%) (Malcovati, Papaemmanuil, Ambaglio, Elena, Galli, et al., 2014). …

    oxford Restricted access

  7. Key players of basal and acquired thermotolerance in the model alga Cyanidioschyzon merolae

    … alga’s serine/arginine rich splicing factor 2 (SRSF2) homolog is identified as a master regulator of the transcriptomic heat shock response and transcriptomic thermomemory, as both are severely impaired in the srsf2 loss-of-function mutant. Additionally, srsf2 is found to be severely impaired in …

    fu-berlin Repository record for Key players of basal and acquired thermotolerance in the model alga Cyanidioschyzon merolae (opens in a new tab)

  8. BIOINFORMATICS ANALYSIS OF FULL-LENGTH RNA NANOPORE SEQUENCING AT SINGLE CELL LEVEL TO STUDY TRANSCRIPTIONAL AND MUTATIONAL PATTERNS IN HUMAN LEUKEMIA

    … SCM-seq was employed to analyze AML samples with SRSF2 spliceosome-factor gene mutations, elucidating the relationship between genetic complexity and transcriptional heterogeneity in malignant and immune compartments. The results confirmed the efficacy of SCM-seq in achieving high-throughput …

    milano Repository record for BIOINFORMATICS ANALYSIS OF FULL-LENGTH RNA NANOPORE SEQUENCING AT SINGLE CELL LEVEL TO STUDY TRANSCRIPTIONAL AND MUTATIONAL PATTERNS IN HUMAN LEUKEMIA (opens in a new tab)

  9. Investigation of the physiological roles of SRSF1-mediated translation

    … phosphorylation of the RS domain. In contrast, SRSF2, another member of the SR family, is unable to shuttle due to the presence of a nuclear retention sequence (NRS) at the C-terminus of its RS domain. When this NRS is fused to SRSF1, it prevents nucleocytoplasmic shuttling of the SRSF1-NRS …

    edinburgh Repository record for Investigation of the physiological roles of SRSF1-mediated translation (opens in a new tab)

  10. Differential Impact of VEGF and FGF2 Signaling Mechanisms on Flt1 Pre-mRNA Splicing

    … pre-mRNA and identified two candidate proteins, SRSF2 and SRSF3, that may be involved in VEGF- or FGF2-induced Flt1 pre-mRNA splicing. Examination of SRSF2 and SRSF3 relative mRNA expression levels, following inhibition of VEGF- and FGF2-activated kinases, indicates that FGF2 significantly …

    vt Repository record for Differential Impact of VEGF and FGF2 Signaling Mechanisms on Flt1 Pre-mRNA Splicing (opens in a new tab)

  11. Mechanistic consequences of splicing factor mutations and their use for targeted cancer therapy

    … commonly mutated splicing factors are SF3B1 and SRSF2. While we know that mutations in each have distinct consequences on splicing, the molecular drivers of disease and sequence characteristics which influence mutant promoted alternative splicing remain unknown. To address this, I first show …

    washington Repository record for Mechanistic consequences of splicing factor mutations and their use for targeted cancer therapy (opens in a new tab)

  12. Development of an improved variant calling pipeline and the analysis of altered allelic transcription of recurrent mutations in Acute Myeloid Leukaemia

    … transcript abundance for GATA2, RUNX1, TET2, SRSF2, IDH2 and NPM1 and preferential wild-type transcript abundance for PTPN11, CEBPA and WT1, respectively. Presence of allelic imbalances among the common variants of GATA2, RUNX1 and IDH2 were also demonstrated in patients without recurrent …

    lmu-germany Repository record for Development of an improved variant calling pipeline and the analysis of altered allelic transcription of recurrent mutations in Acute Myeloid Leukaemia (opens in a new tab)

  13. Investigation Of The Role For Methyl-Cpg Binding Protein 2 Variant Mbd2_v2 In Cancer Stem Cells And Obesity-Associated Cancers

    … patients, and demonstrating the importance of SRSF2-MBD2_v2 mediated expression of pluripotency transcription factors in driving tumor-initiating TNBC CSCs via DIO and PCa CSCs via STAT3-dependent IL-6 signaling.

    wayne-thes Repository record for Investigation Of The Role For Methyl-Cpg Binding Protein 2 Variant Mbd2_v2 In Cancer Stem Cells And Obesity-Associated Cancers (opens in a new tab)

  14. INVESTIGATING THE EFFECT OF PRMT INHIBITORS ON MYELOID LEUKEMIAS WITH SPLICEOSOMAL GENE MUTATIONS

    … most commonly mutated splicing factors include SRSF2, SF3B1, U2AF1 and ZRSR2. These mutations occur in a heterozygous and mutually exclusive manner, suggesting that cells cannot tolerate the perturbation of splicing beyond a single allele mutation. These observations have fuelled recent clinical …

    nus Repository record for INVESTIGATING THE EFFECT OF PRMT INHIBITORS ON MYELOID LEUKEMIAS WITH SPLICEOSOMAL GENE MUTATIONS (opens in a new tab) Download file for INVESTIGATING THE EFFECT OF PRMT INHIBITORS ON MYELOID LEUKEMIAS WITH SPLICEOSOMAL GENE MUTATIONS (opens in a new tab)

  15. Understanding the mechanistic and functional consequences of splicing factor mutations

    … identified 11 rare mutations in splicing factors SRSF2 and U2AF1 with likely disease pathogenicity, as well as two mis-spliced events with disease relevance driven by a hotspot mutation in SF3B1.

    washington Repository record for Understanding the mechanistic and functional consequences of splicing factor mutations (opens in a new tab)

  16. PARP1 inhibition preferentially sensitizes spliceosome mutant leukemias through R-loop-associated genomic vulnerabilities

    … with myeloid malignancies. Here, we showed that SRSF2- and U2AF1-mutant leukemias are preferentially sensitive to PARP inhibitors (PARPi) despite being proficient in homologous recombination repair. Instead, SF-mutant leukemias exhibited R-loop accumulation that elicited an R-loop–associated …

    umn Repository record for PARP1 inhibition preferentially sensitizes spliceosome mutant leukemias through R-loop-associated genomic vulnerabilities (opens in a new tab)

  17. Su onkologinėmis ligomis siejamas pre-iRNR splaisingas: splaisingo veiksnių ir hipoksinės mikroaplinkos tyrimas /

    … shown differences in the expression of SRSF1, SRSF2, U2AF65, U2AF35 and KHSRP splicing factors and tumor-associated Fas and Rac1 mRNA isoforms in tumor tissues and commonly used tumor cell lines. Our results indicate that reduced oxygen content in the cell environment (hypoxia) affects Fas …

    vilnius Repository record for Su onkologinėmis ligomis siejamas pre-iRNR splaisingas: splaisingo veiksnių ir hipoksinės mikroaplinkos tyrimas / (opens in a new tab)

  18. Kanoninių ir mirtroninių miRNR funkcinis tyrimas krūtinės kylančiosios aortos aneurizmos audiniuose ir virškinimo sistemos navikuose /

    … we determined that splicing factors SRSF1 and SRSF2 promote mirtronic miRNA biogenesis. Finally, we identified that mirtronic miRNAs were differentially expressed in the digestive system cancer cell lines and tumors.

    vilnius Repository record for Kanoninių ir mirtroninių miRNR funkcinis tyrimas krūtinės kylančiosios aortos aneurizmos audiniuose ir virškinimo sistemos navikuose / (opens in a new tab)

  19. INTEGRATED SINGLE-CELL MUTATION, GENE EXPRESSION AND ISOFORM ANALYSIS TO DECONVOLVE ACUTE MYELOID LEUKEMIA HETEROGENEITY

    … complexity. In all lineages, the presence of the SRSF2 mutation was associated to increased isoforms diversity, with mutated cells carrying significantly higher proportions of genes expressed with more than one isoform or expressing novel or alternative transcripts, as compared to AML …

    milano Repository record for INTEGRATED SINGLE-CELL MUTATION, GENE EXPRESSION AND ISOFORM ANALYSIS TO DECONVOLVE ACUTE MYELOID LEUKEMIA HETEROGENEITY (opens in a new tab)

Page 1 of 2